Back
ProShares Ultra Nasdaq Biotechnology Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
$45.08
Seasonality Move:
13.34%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
ProShares Ultra Nasdaq Biotechnology Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.89 | Buy |
| 20-day SMA: | 42.88 | Buy |
| 50-day SMA: | 49.6 | Sell |
| 200-day SMA: | 57.81 | Sell |
| 8-day EMA: | 43.44 | Buy |
| 20-day EMA: | 44.15 | Buy |
| 50-day EMA: | 47.83 | Sell |
| 200-day EMA: | 54.28 | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.69 | Sell |
| Relative Strength Index (14 RSI): | 48.74 | Sell |
| Chaikin Money Flow: | -1778 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.88 - 49.6) | Sell |
| Bollinger Bands (100): | (46.65 - 57.33) | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProShares Ultra Nasdaq Biotechnology Stock
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 44.61 while BIB 8-day simple moving average is 42.89, which is a Buy signal.
-
The stock price of BIB is 44.61 while ProShares Ultra Nasdaq Biotechnology 20-day SMA is 42.88, which makes it a Buy.
-
ProShares Ultra Nasdaq Biotechnology 50-day simple moving average is 49.60 while BIB share price is 44.61, making it a Sell technically.
-
BIB stock price is 44.61 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 57.81, creating a Sell signal.
BIB Technical Analysis vs Fundamental Analysis
Sell
39
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a SellThe current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $44.61. The Score for BIB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
ProShares Ultra Nasdaq Biotechnology Stock Info
Market Cap:
0
Price in USD:
44.61
Share Volume:
2.8K
ProShares Ultra Nasdaq Biotechnology 52-Week Range
52-Week High:
69.56
52-Week Low:
33.78
Sell
39
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
ProShares Ultra Nasdaq Biotechnology Share Price Forecast
-
What is the ProShares Ultra Nasdaq Biotechnology stock price today?The ProShares Ultra Nasdaq Biotechnology stock price is 44.61 USD today.
-
Will BIB stock go up or go down?ProShares Ultra Nasdaq Biotechnology> share price is forecast to RISE/FALL based on technical indicators
-
Is ProShares Ultra Nasdaq Biotechnology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProShares Ultra Nasdaq Biotechnology is overvalued.
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 44.61 while BIB 8-day exponential moving average is 43.44, which is a Buy signal.
-
The stock price of BIB is 44.61 while ProShares Ultra Nasdaq Biotechnology 20-day EMA is 44.15, which makes it a Buy.
-
ProShares Ultra Nasdaq Biotechnology 50-day exponential moving average is 47.83 while BIB share price is 44.61, making it a Sell technically.
-
BIB stock price is 44.61 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 54.28, creating a Sell signal.
Technical Analysis of ProShares Ultra Nasdaq Biotechnology
Should I short ProShares Ultra Nasdaq Biotechnology stock?
-
BIB Moving Average Covergence Divergence (MACD) indicator is -1.69, suggesting ProShares Ultra Nasdaq Biotechnology is a Sell
-
ProShares Ultra Nasdaq Biotechnology Relative Strength Index (RSI) is 48.74, which suggest ProShares Ultra Nasdaq Biotechnology is oversold
-
The Bollinger Bands (25) for ProShares Ultra Nasdaq Biotechnology is (39.88 - 49.6), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
-
The Bollinger Bands (100) for ProShares Ultra Nasdaq Biotechnology is (46.65 - 57.33), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.